SaxoCell Conference 2026

SaxoCell Conference 2026
Go back

SaxoCell Conference 2026

From Lab to Life: Advancing Cell and Gene Therapies Together

Join us at the SaxoCell Conference 2026 in Dresden, where leading minds from science,industry, and politics come together to shape the future of safe and accessible cell and genetherapies — bridging innovation and implementation.

The SaxoCell Conference 2026 is your opportunity to engage with experts, innovators, and decision makers in the field of cell and gene therapies. As part of the BMBF Clusters4Future initiative, SaxoCell is one of Germany’s leading centres dedicated to researching new applications and production methods for personalised therapies and ‘living drugs’.

What to Expect:

  • Insights into the latest scientific advancements in cell and gene therapies.
  • Opportunities to network with professionals from academia, industry, and policy.
  • Discussions on how Germany is contributing to the future of Cell and Gene Therapy.

Date: 02 – 03 June 2026
Location: Penck Hotel, Dresden

Whether you’re a scientist, industry leader, or policymaker, the SaxoCell Conference offers a platform to
exchange ideas and collaborate on shaping the future of healthcare.

You can find more information about SaxoCell at www.saxocell.de

Register now to be part of this important event!

https://eveeno.com/saxocell_conference_2026

BioRN members receive a 20 % discount.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
Workflow Optimisation in the Laboratory: Premiere of the smartLabs Summit in Heidelberg

Workflow Optimisation in the Laboratory: Premiere of the smartLabs Summit in Heidelberg

On September 24, 2025, the smartLabs Summit will open its doors for the first time in Heidelberg – an event dedicated to practical innovation, digitalization, and automation in laboratories. The Summit will take place at BioLabs Heidelberg (Nicola-Tesla Straße 1–3, 69124 Heidelberg) and offers a full program from 1:00 to 7:30 p.m. Initiated by the […]

read more
DFG awards Heidelberg research project on early detection of spinal degeneration nearly €250,000 in funding

DFG awards Heidelberg research project on early detection of spinal degeneration nearly €250,000 in funding

The aim of the project is to use special quantitative MRI to visualize early changes in the intervertebral disc and enable timely treatment. Ultrashort echo time (UTE) MRI opens up completely new approaches to preventive imaging that are difficult or impossible to achieve with conventional MRI methods. Full text in German below. DFG fördert Heidelberger […]

read more
Glioblastoma study shows: Molecular diagnostics could enable targeted therapies without delay

Glioblastoma study shows: Molecular diagnostics could enable targeted therapies without delay

Researchers from Heidelberg University’s Medical Faculty, the German Cancer Research Center (DKFZ), and the National Center for Tumor Diseases (NCT) in Heidelberg have tested the use of targeted drugs in the initial treatment of newly diagnosed glioblastoma, an extremely aggressive brain tumor, in the multicenter study “NCT Neuro Master Match (N2M2)”. Of the five drugs […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp